Novartis AG (LON:0QLR)
London flag London · Delayed Price · Currency is GBP · Price in CHF
126.40
-1.60 (-1.25%)
At close: Feb 20, 2026

Novartis AG Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
230,688197,052156,316162,643161,382145,494
Market Cap Growth
38.11%26.06%-3.89%0.78%10.92%-7.63%
Enterprise Value
249,142214,069170,040173,261169,844165,439
Last Close Price
120.84102.7875.3773.1864.0152.92
PE Ratio
22.2018.9716.3913.9527.968.20
PS Ratio
5.484.683.784.444.474.48
PB Ratio
6.675.704.434.433.272.91
P/TBV Ratio
-----21.01
P/FCF Ratio
17.6515.0712.0415.4614.6014.07
P/OCF Ratio
16.2213.8511.1114.3313.6613.07
EV/Sales Ratio
5.805.084.124.734.715.09
EV/EBITDA Ratio
13.8512.2710.3012.1514.6814.33
EV/EBIT Ratio
17.3015.1613.0421.5722.2120.43
EV/FCF Ratio
19.0616.3713.1016.4715.3616.00
Debt / Equity Ratio
0.760.760.710.570.470.46
Debt / EBITDA Ratio
1.491.491.501.441.971.95
Debt / FCF Ratio
2.022.021.931.972.102.22
Net Debt / Equity Ratio
0.510.510.410.270.160.04
Net Debt / EBITDA Ratio
1.021.020.870.680.660.18
Net Debt / FCF Ratio
1.361.361.110.920.690.21
Asset Turnover
0.530.530.510.430.350.34
Inventory Turnover
2.272.272.201.911.671.65
Quick Ratio
0.820.820.780.881.001.25
Current Ratio
1.121.121.031.161.291.51
Return on Equity (ROE)
30.81%30.81%26.27%16.15%9.51%36.80%
Return on Assets (ROA)
11.14%11.14%10.09%5.88%4.62%5.28%
Return on Invested Capital (ROIC)
23.60%24.47%23.55%15.05%11.14%13.29%
Return on Capital Employed (ROCE)
22.70%22.70%22.20%13.90%10.40%10.80%
Earnings Yield
4.50%5.27%6.10%7.17%3.58%12.19%
FCF Yield
5.67%6.64%8.30%6.47%6.85%7.11%
Dividend Yield
2.43%3.37%4.09%4.21%4.49%4.75%
Payout Ratio
55.91%55.91%63.85%48.85%107.92%30.67%
Buyback Yield / Dilution
3.93%3.93%2.73%4.78%2.79%1.57%
Total Shareholder Return
6.36%7.30%6.82%8.98%7.27%6.31%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.